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Cutis laxa is a genetically heterogeneous connective tissue 
disease that occurs in both inherited and acquired forms. The 
most apparent defect is loose, redundant, nonresilient skin, 
but systemic cOlU1ective tissue abnormalities exist, especially 
in conjunction with the early onset or autosomal recessive 
variety. The elastic fiber shows morphologic alterations. We 
studied dermal skin biopsies and cultured skin fibroblasts 
from 6 patients with congenital forms of cutis laxa in an 
effort to correlate alterations in elastin morphology and me-
tabolism. In general, ultrastructural analysis revealed occa-
sional variance in collagen fiber diameter, whereas elastic 
tissue varied in content, appearance, and the proportion and 
manner by which elastin and microfibrillar component asso-
ciated. Fibroblast cell lines comprised of normal donors from 
C utis laxa is one of a variety of clinically and geneti-cally heterogeneous connective tissue diseases and may be acquired or inherited in a dominant [1,2] or an autosomal recessive [1,3 - 5] manner. Although clini-cal distinctions are not precise, in general the autoso-
ma l dominant form is less severe with late onset of dermal laxity and 
rare involvement of organs . The autosomal recessive disease is usu-
ally present at birth and is characterized by extreme skin laxity and 
systemic involvement. Acquired forms of the disease often exist as a 
complication of an inflammatory episode [6-9]. An X-linked form 
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Abbreviations: 
DMEM: Dulbecco's modified Eagle's medium 
EDS: Eh lers-Danlos syndrome 
FCS: fetal calf serum 
HBSS: Hank's balanced salt solution 
HPLC: high performance liquid chromatography 
mRN A: messenger RNA 
NETS buffer: 100 mM NaCI, 10 mM Tris-HCI, pH 7.5,1 mM 
EDTA, pH 7.5, 0.2% sodium dodecyl sulfate 
PTC: phenylthiocarbamyl 
SDS: sodium dodecyl sulfate 
SSC: 0.15M NaCI, 0.015M NaCitrate, pH 6.8 
TAE: 10 mM Tris, 5 mM NaOAc, pH 7.8, 0.5 mM EDTA 
TE: tropoelastin 
a similar age group produced an average of 35 ± 10 X 103 
tropoelastin molecular equivalents per cell per hour, as mea-
sured by an ELISA. Three of six cutis laxa cell strains were 
markedly (5 - 20-fold) reduced in tropoelastin production. 
Two of these cell strains had specifically reduced levels of 
tropoelastin production relative to total protein synthesis. 
Analysis of elastin specific messenger RNA levels indicated 
this reduced expression of tropoelastin was regulated at a 
pretranslational level. In other strains, diminished produc-
tion of elastin did not appear to be the primary defect, under-
scoring the heterogeneous nature of cutis laxa at both the 
biochemical and ultrastructural levels. ] Invest Dermatol 
93:147-153,1989 
of cutis laxa (subsequently described as Ehlers-Danlos syndrome 
type IX; EDS) has also been described, which results from defective 
copper utilization leading to decreased activity of copper-dependent 
enzymes such as lysyl oxidase [10-13]. 
Characterization of heritable cutis laxa has been largely restricted 
to clinical observations [1,3,4] and occasional histologic and ultra-
structural descriptions [2,5,14]. In the severe congenital forms of 
cutis laxa there are widespread aberrations of elastic tissues and 
occasional irregularities in collagen morphology with little evi-
dence of abnormal collagen metabolism. Although abnormalities in 
the synthesis of collagens I and III have not been found [15,16], 
fibroblasts from one affected individual, included in the present 
study, were reported to synthesize increased amounts of collagen VI 
[15]. The functions of this extracellular glycoprotein are undefined. 
Although it is found in elastic tissue, its tissue distribution is very 
broad [17], and there is no immunologic relationship between the 
microfibrillar component of elastic fibers and type VI collagen [18]. 
Morphologic studies of skin biopsies from individuals with con-
genital forms of cutis laxa [14] frequently reveal alterations ill. the 
quantity and morphology of elastic fibers, and there is often a pau-
city of elastic fibers or an abnormal organization of the fibers . The 
microfibrillar component, a matrix structure that is laid down in 
association with elastin, may appear altered in organization, in 
creased in quantity, or may be laid down separate from the elastin 
component [14]. The variations in morphology of elastic fibers 
among skin samples from individuals with cutis laxa suggest that 
the biochemical basis of the disorder may be heterogeneous. Indeed, 
it is possible that cutis laxa could result from mutations that affect 
the synthesis, stabilization, or degradation of elastic fibers. Defects 
may involve genes encoding elastin, elastases, elastase inhibitors, 
microfibrillar component(s), collagen, or those that affect lysyl oxi-
dase, as previously noted for X-linked cutis laxa (EDS IX). Elasto-
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lytic degradation is a component of the cutis laxa phenotype in one 
patient, whose serum expressed increased elastase levels [19]. 
Despite ultrastructural evidence of diminished elastin accumula-
tion, comprehensive studies of elastin synthesis or degradation in 
cutis laxa have not been done. While this manuscript was in revision 
a study was published that demonstrated reduced elastin messenger 
RNA (mRNA) levels in several cutis laxa cell strains, however, the 
findings were not correlated to ultrastructural morphology or pro-
tein expression [20]. Biochemical evaluation should permit another 
level of distinction among potential cutis laxa subtypes, as well as 
among related diseases. Based on previously established conditions 
for analysis of tropoelastin expression by cuI tured human skin fibro-
blasts [21- 24], we have studied cells from 6 individuals diagnosed 
with early onset forms of cutis laxa. Cells from two affected individ-
uals synthesized significantly less tropoelastin than did controls; 
because tropoelastin mRNA levels were correspondingly reduced, 
the decreased synthesis appeared to be regulated at a pretranslational 
level. In other patients studied, however, early onset cutis laxa re-
sulted from factors other than a phenotype of decreased fibroblast 
elastin production. 
MATERIALS AND METHODS 
Electron Microscopy Two- or three-millimeter dermal skin 
biopsies were fixed in half-strength Karnovsky's fixative, washed in 
0.1 M cacodylate buffer, postfixed in 1 % osmium tetroxide, dehy-
drated through alcohol, and embedded in Epon. Thin sections were 
floated on drops of 1 % aqueous phosphotungstic acid for 4 h, 
washed and stained with saturated uranyl acetate and lead citrate, 
and then examined in a Philips 201 or Philips 401 transmission 
electron microscope. 
Human Skin Fibroblast Cultures Cutis laxa skin fibroblasts 
were grown from upper arm biopsies of 6 infants or young children 
(19 d - 6 yr in age); all biopsies were taken with appropriate con-
sent. Age-matched control skin fibroblasts were obtained from the 
National Institute of General Medical Sciences Human Genetic 
Mutant Cell Repository or the National Institute on Aging, Aging 
Cell Repository. Fibroblast cultures were routinely maintained at 
37°C in a humidified 10% COr 90% air atmosphere in Dulbecco's 
modified Eagle's medium (DMEM) containing HEPES buffer 
(25 mM, pH 7.6), 100 V/ml penicillin, 100,ug/ml streptomycin, 
nonessential amino acids (Flow Laboratories, McLean, VA, or 
GIBCO, Grand Island, NY) and 10 or 20% heat-inactivated fetal 
calf serum (FCS) (Flow Laboratories or Hyclone, Logan, VT). Elas-
tin synthesis and elastin mRNA levels were measured at passages 
5 - 11. At these passage levels, tropoelastin production is relatively 
constant in confluent cultures, and it varies little among trunk or 
limb donor sites [22]. Cells were subcultivated by detaching with 
0.25% trypsin in Hank's balanced salt solution (HBSS) and replated 
at 1: 4 split ratios on 25 cm2 flasks (Corning, Corning, NY) . 
Total Protein Synthesis Skin fibroblasts from four normal cell 
strains and six cutis laxa cell strains were subcultivated in triplicate 
to six-well plates (35-mm wells), allowed to reach visual confluency 
and fed with 2 ml fresh DMEM containing 10% FCS (Hyclone) . 
The medium was harvested 48 h later for quantitation of tropoelas-
tin by ELISA. Cell layers were rinsed twice with HBSS and incu-
bated for 3 h with 1 ml ofleucine-free DMEM ("Selectamine" Kit, 
GIBCO) containing 10% dialyzed FCS and 5 ,uCi/ml L-(4,5-[3HJ)-
leucine (Amersham Arlington Heights, IL) with a specific activity 
of 120 Ci/mMol. The labeling medium was removed before cell 
layers were rinsed twice with HBSS and scraped into 800,u1 of 0.1 N 
NH40H. The lysate was heat-inactivated at 100°C for 5 min, soni-
cated briefly, and clarified by centrifugation. Aliquots were taken to 
quantify the DNA content of the cell layer and remainder of the 
sample was dialyzed (Spectrapor cellulose dialysis tubing, mol wt 
cutoff 12,000) against water. The initial dialysates (15 volumes) 
were used to estimate intracellular leucine pool specific activities as 
described below. Aliquots (100 ,ul) of the retentate were added to 3.5 
ml Scinta-Verse II (Fisher Pittsburgh, PA) scintillation cocktail and 
counted on a PRIAS scinti llation counter (Packard Meriden, Conn) 
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to determine total (3H]-leucine counts incorporated into protein, 
further correcting for volume and cell number. 
The labeling medium was similarly dialyzed, and total incorpora-
tion into secreted proteins was normalized to cell number. The 
percent of secreted protein was determined by dividing the dpm/ 
cell value for the medium by the total dpm/cell of cell lysate plus 
the medium. 
Specific Activity Determinations Dialysable fractions of la-
beled cell mono layers for each strain tested were frozen at -80°C 
and lyophilized. Samples were derivatized in 1 ml of70% ethanol, 
10% triethylamine, 10% phenylisothiocyanate, and 10% H 20. 
This reaction mixture was allowed to stand at room temperature for 
20 min after which the solvents were removed in a vacuum desicca-
tor before resolubilizing the sample in 1 ml of 50 mM NaOAc, pH 
6.8. Aliquots of the phenylthiocarbamyl (PTC)-amino acids were 
injected into a Beckman high-performance liquid chromatography 
(HPLC) system equipped with an Vltrasphere ODS column (4.6 
mm X IS cm, Beckman, Fuller,ton, CA). The gradient of buffer A 
(50 mM NaOAc, pH 6.8) and buffer B (50 mM NaOAc in 80% 
methanol, pH 6.0) was 22.5% buffer B for 12 min, 45% buffer B for 
1.2 min, 55% buffer B for 15 min, and 10% buffer B for 2 min. 
Absorbance was measured on a variable wavelength detector at 254 
nm and peak areas were quantified with a Hewlett Packard 9133A 
computer using Nelson Analytical software. Fractions correspond-
ing to the PTC-Ieucine peak were counted by liquid scintillation 
counting. 
Specific activities of intracellular leucine pools were estimated by 
dividing dpm of[3H]-PTC-leucine recovered by the amount (nano-
moles) of leucine in each sample, as measured by integration of 
leucine peaks isolated by HPLC. The specific activity was entered 
into the following equation: 
(A X B)/(C X D) = E 
where: A = F.W. ofleucine (131.13 g/mole); B = total dpm/cell; 
C = specific activity (in dpm/mole ofleucine); D = percent ofleu-
cine in total protein of celllayer/100 (0.074); E = total estimated 
protein produced per cell (g/cell). 
Enzyme-Linked Immunoassay Elastin production by human 
skin fibroblasts was measured by an enzyme-linked immunoassay as 
previously described [21,22,24]. Human skin fibroblast culture me-
dium (DMEM with 10% FCS) was harvested after a 48 - 72-h incu-
bation on confluent cell monolayers in 25 cm2 flasks (Corning) or 
six-well plates (Costar), aliquoted, and stored at -20°C. Samples 
were thawed at 4 ° C before serial dilution in phosphate-buffered 
saline, pH 7.4, Tween-20 - Triton X-I 00 (0.05% each). Values for 
tropoelastin production were estimated by fitting optical density 
values of unknowns to a standard curve constructed from a four-pa-
rameter, nonlinear regression analysis [25] performed on an Apple 
11+ microcomputer. 
DNA Assay Cell number was estimated by a modification of the 
fluorimetric DNA assay ofHinegardner [26] as previously described 
[27] . 
Detection of Elastin mRNA by Northern Hybridization 
Total RNA was isolated from confluent human skin fibroblasts 
(3 .5 - 4.5 X 107 cells per 3 X 150-cm2 plate, grown in DMEM plus 
20% FCS) by a modification of the method of Chirgwin et al [28]. 
Cells were lysed in approximately 10 volumes of a solution contain-
ing 0.1 M Tris-HCI, pH 6.5, 6M guanidine-HCI, 10 mM dithio-
threitol, 1 % N -lauroyl sarcosine, and frozen at -80 ° C. The extracts 
were subsequently thawed, and EDT A, pH 8.0 was added to a final 
concentration of 20 mM. The extracts were layered over a cushion 
of 5.7 M CsCI buffered with 0 .1 M EDT A (pH 7.0) and centrifuged 
at 36,000 rpm for 22 h (20 °C) in a Beckman SW 50.1 rotor. The 
pellets were redissolved in 1 mM EDTA (pH 7.0) and heated briefly 
at 65°C. An equal volume of2 X NETS buffer (1 X NETS = 100 
mM NaCI, 10 mM Tris-HCl, pH 7.5,1 mMEDTA, pH 7.5, 0.2% 
sodium dodecyl sulfate [SDSJ) was added and the sample was again 
briefly heated and immediately cooled on ice. Poly [A]+-RNA was 
purified by passing total RNA over a poly [V]-Sepharose (Sigma) 
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column previously equilibrated with NETS and eluting the bouncl 
mRNA with four column volumes of elution buffer consisting ofl0 
mM Tris-HCI, pH 7.5,100 mM NaCI, 10 mM EDTA, and 90% 
formamide (Fluka, Ronkonkoma, NY). Efficiency of mRNA re-
covery was monitored by addition of [3H]-globin mRNA from di-
methyl sulfoxide-induced K562 erythroleukemia cells grown in the 
presence of (3H]-uridine [29]. 
PolyA+-RNA was size-fractionated on a denaturing 1 % agarose 
gel containing 2.2 M formaldehyde in 10 mM phosphate buffer, pH 
7.4. Sheep nuchal ligament RNA, highly enriched in elastin mRNA 
was used as a reference. The RNA was transferred to nylon-based 
filters (Nytran; Schleicher and Schuell, Keene, NH) by electropho-
retic transfer in 1 X 10 mM Tris, 5 mM NaOAc, pH 7.8, 0.5 mM 
EOTA (T AE) at 12.5 V for 2 hand 40 V for 12 h. Filters were rinsed 
in 6 X SSC (1 X SSC = 0.15 M N aCI in 15 mM sodium citrate, pH 
6.8) before prehybridization at 44 ° C overnight in a solution of 50% 
deionized formamide, 0.1 % SOS, 5 X SSC, 5 X Oenhardt's solu-
tion, 50 mM sodium phosphate, pH 6.7, and 250 I1g/ml of dena-
tured, sonicated herring sperm DNA. Hybridization was carried out 
using 250 ng of nick-translated [30] pSEl-1.3 elastin probe (=4 X 
107 cpm/l1g) in a similar solution substituting 1 X Oenhardts, 20 
mM phosphate buffer, 100 mg/ml herring sperm DNA. This sub-
cloned fragment of the sheep elastin gene encodes 619bp out of 974 
bp of the 3' untranslated region and 41 bp of the 3' coding domain 
of elastin mRNA [31]. This probe reacts specifically with a 3.5-kb 
mRNA, the size of elastin mRNA [23,32]. The hybridization reac-
tion was incubated at 47"C for 24 h, after which time filters were 
washed twice with 5 X SSC, 1.0% SDS at room temperature, twice 
for 15 min in 1 X SSC, 1.0% SDS at 37°C, and once with 0.1 X 
SSC, 1.0% SDS at 60°C for 15 min. X-ray film (X-Omat AR, 
Eastman Kodak Co., Rochester, NY) was exposed to filters at 
-70 ° C in cassettes equipped with intensifying screens. 
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Degradation of125I_ Tropoelastin in Fibroblast Culture Eval-
uation of tropoelastin degradation by cultures from normal and cutis 
lax a-derived fibroblasts strains was performed as previously de-
scribed .[21 ,23]. 
RESULTS 
Clinical Description, Histology, and Ultrastructure All cutis 
laxa patients studied were remarked to exhibit severe skin laxity at 
birth, accompanied by systemic abnormalities in all but one case 
(Table I). There was no perceptible joint hyperextensibility noted. 
Two types of elastic fiber morphology were apparent in skin biop-
sies. The elastin component of the fibers appeared diminished in 
patients SH, SS, KT, and variably in KL (Fig lA,E,C,B, respec-
tively). The other prevalent morphologic abnormality involved al-
tered association of the fiber components with each other (DP, Fig 
ID; HC, Fig IF) or with collagen fibers (KL, Fig IB). Irregularity 
of collagen fibers, themselves, was not remarkable, except for pa-
tient SH, whose fibers were noticeably reduced in size (Fig lA). 
Collagen fibers were, otherwise, either normal (SS, Fig IE; KT, Fig 
lC; KL, Fig IB), mildly decreased in size (HC, Fig IF), or some-
what variable in diameter (OP, Fig ID). 
Total Tropoelastin Production Skin fibroblasts from normal 
age matched donors produced 24.5 to 58.5 X 103 tropoelastin (TE) 
equivalents per cell per hour (Fig 2) . Three cutis laxa-derived cell 
strains (DP, SH, SS) produced normal or near normal quantities of 
TE, whereas three others (HC, KL, KT) produced 5, 4, and 1 X 103 
TE equivalents per cell per hour, respectively, values that were 
significantly less than normal (p<0.006, I -tailed Mann-Whitney 
U test). 
Relative Tropoelastin Production Relative TE production was 
determined by measuring incorporation of a metabolic label into the 
Table I. Clinical and Ultrastructural Features of Cutis Laxa Patients 
Patient Age' 
DP 19 d 
SH 1 mo 
HC 7 mo 
SS 14 mo 
KT 24 mo 
KL 6 yr 
• Age at time of biopsy. 
Sex 
M 
M 
F 
F 
M 
F 
C linical Description 
Markedly loose skin, dilated aortic sinus, bilateral 
inguinal hernias, normal joint mobility 
Excessive, redundant, lax, wrinkling skin; 
epicanthal folds, long philtrum, epigastric 
ventral hernia, respiratory problems at birth. 
Reduced serum copper and ceruplasmin, 
possibly caused by dietary uptake, liver disease, 
and prematurity with low birth weight. 
N ormal copper uptake by fibroblasts 
Loose, nonelastic skin; diaphragmatic, bilateral 
inguinal, umbilical, and sciatic notch hernias; 
bowel prolapse; persistent tachypnea; long 
philturm 
Marked redundancy of skin with "hound dog" 
facial appearance. Pulmonary disease; dilated 
aortic root 
Severe skin laxity; subglottic stenosis; mild 
laryngomalacia; dilated pulmonary artery and 
aortic arch 
Excessively loose skin; small palpebral fissures; 
long philtrum 
, LM = light microscopy; EM = electron microscopy; MF = microfibrillar component. 
Histology / Ultrastructureb 
Elastic Fibers: Variable, large with dense elastin, obscuring 
MF, outer ragged rim of elastin that appeared to be 
added to the formed fiber, inclusions that look like 
debris, separation of microfibrillar component and elastin. 
Collagen Fibers: Large, well-integrated fibers, some with 
variable diameter. 
Elastic Fibers: Both elastin and MF component minimal, 
barely perceptible by LM. By EM, fibers were very 
small but morphology appeared normal. 
Collagetl Fibers: Very small , separated by large areas of 
interstitial space. 
Elastic Fibers: By LM, appeared as beaded strands bordering 
collagen bundles. By EM, elastin and microfibrillar 
components deposited independently. Elastin appeared 
as small beads scattered in MF array. 
Collagetl Fibers: Collagen bundles in dermis small, appeared 
to be large areas of interstitial space. 
Elastic Fibers: Large amount of MF component with a 
paucity of elastin component within the MF network. 
Collagell Fibers: Dermal collagen bundles dense and 
normally interwoven 
Elastic Fibers: Bizarre elastic fibers with little amorphous 
elastin component. MF matrix abundunt containing rare 
sma ll globules of elastinlike electron density. These 
abnormal fibers present around periphery of fibroblasts, 
macrophages , and smooth muscle cells. 
Collagell Fibers: Dermal collagen bundles appeared normal. 
Elastic Fibers: Variable structure. Large, dense, fragmented 
structures which were not at the edge of collagen 
bundles but integrated with the fibers . Some fibers were 
very smaIl and contained only small amounts of elastin. 
Collagel1 Fibers: Dermal collagen bundles appeared normal. 
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Figure 1. Ultrastructure of dcrmal biopsies from cutis laxa patients. A: Small elastic fibers (arrow) present in the reticular dermis of SH. Elastin and 
microfibrillar components are evident, although both are present in less quantity than expected in the normal reticular dermis. X 10,000. B: Elastic fibers 
present in the reticular dermis of KL. This is one of the various morphologies of the fibers in the skin of this patient and is comparable with those in the skin of 
the patient in (A). X 10,000. C: Elastic fibers from the reticular dermis ofKT. The hallmark of these fibers throughout the dermis is a marked paucity of elastin 
present in the bundles of microfibrils. X 10,000. D: Elastic fibers in the reticular dermis of DP. There is an abundance of elastin and the microfibrils arc visible 
within this substance as small densities. X 10,000. E: Elastic fibers in the reticular dermis of SS. These fibers have an excessive amount of microfibrils and a 
diminished content of elastin compared with those in the normal dermis. X 10,000. F: Elastic fibers from the reticu lar dermis of He. The elastin component 
appears to be deposited independent (large arrow) of the microfibrils (sl1Iall arrow) . The amount of both components appears reduced compared with those of 
normal fibers. X 10,000. 
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Figure 2. Tropoelastin production in normal and cutis laxa skin fibroblasts. 
Skin fibroblast cultures, which had reached visual confluency, were incu-
bated with DMEM containing 10% FCS for 72 h. Medium was harvested 
and values for TE content (ng/ml) were derived by an ELISA. Cell layers 
were assayed for DNA content by a fluorometric assay using diaminobenzoic 
acid. The average of triplicate flasks was determined, and the data were 
expressed as molecular equivalents per cell per hour ± SEM. Control fibro-
blasts were obtained primarily from the National Institute of General Medi-
cal Sciences, Human Genetic Mutant Cell Repository (GM prefix) or the 
National Institute on Aging, Aging Cell Repository (AG prefix) and are 
designated in order as follows: 3-d foreskin (SW-8, gift of Dr. H. S. Wiley, 
Universiry of Utah) , 3-d foreskin (AG 1520), 3-d male skin (GM 0970A), 
2-mo male inguinal skin (GM 5756), 10-mo male trunk skin (GM 302A), 
14-mo male trunk skin (GM 5659), 24-mo female skin (GM 969A), and 
10-yr male inguinal skin (GM 3348A). 
total protein from both cell layers and culture media (Fig 3, lower 
panel) . Two normal fibroblast strains incorporated 1.6 and 1.8 dpm 
of(3HJ-leucine per cell, while the incorporation of six cutis laxa-de-
rived fibroblast strains ranged from 0 .8 to 3.2 dpm of [3HJ-Ieucine 
per cell. Specific activities of cellular leucine pools were used to 
estimate total protein synthesis from total incorporation data (Fig 3, 
middle panel). Levels of total protein synthesis for both normal and 
cutis laxa cell strains paralleled their incorporation data, indicating a 
uniformity of ce llular leucine pools. Absolute TE production was 
determined for media incubated on the cells for the 48 h preceding 
metabolic labeling and expressed relative to total protein synthesis 
(Fig 3, upper panel). One cutis laxa strain, HC, had reduced levels of 
abso lute production, but relative TE production fell within the nor-
mal range, apparently due to reduced total protein synthesis. Fi-
broblast strain SS produced slightly reduced abso lute and relative 
levels of elastin. Two other cutis laxa strains, KL and KT, exhibited 
significantly 'diminished absolute and relative TE production. Fi-
broblasts' from KL expressed measurable but substantially reduced 
levels of TE whereas KT fibroblasts produced TE at background 
leve ls. 
Northern Blot Analysis of Elastin mRNA Equivalent amounts 
of poly [AJ+-RNA isolated from normal and cutis laxa fibroblasts 
was qualitatively and quantitatively examined by Northern hybri-
dization using an elastin-specific genomic probe (Fig 4). Transcripts 
from normal and cutis laxa-derived cell strains migrated at approxi-
mately 3.5 kb, parallel to the standard sheep nuchal ·ligament elastin 
mRNA. Cutis laxa cell strain HC expressed normal levels of tran-
script, in agreement with relative protein expression data. De-
creased levels of elastin-specific transcripts in cutis laxa strains KL 
and KT coincide with the reduction of TE production measured at 
the protein level. 
Contribution of Tropoelastin Degradation We investigated 
the possibility that extracellular degradation ofTE was responsible 
for reduced expression in cell strains from individuals affected with 
cutis laxa. Culture cell s from affected donors, incubated for up to 72 
h with media containing 1251_ TE, showed no increase in 
ELASTIN DEFECTS IN CUTIS LAXA 151 
Cl3CCOOH-soluble counts over normal cell strains treated simi-
larly. Degradation of radiolabeled TE was negligible in all cases 
(data not shown) . 
DISCUSSION 
Cutis laxa is characterized by sagging, wrinkled skin. Some varieties 
of this clinical entity, especially those of congenital onset, are com-
plicated by systemic organ involvement. Severe pulmonary disease, 
Figure 3. Total protein production and relative elastin production in nor-
mal and cutis laxa fibroblasts . Confluent skin fibroblast cell strains from 
normal and affected donors were incubated with DMEM containing 10% 
FCS for 48 h. Medium was harvested for determination ofTE production by 
ELISA. Cell layers were incubated for 3 h with leucine-free DMEM con-
taining 10% dialyzed FCS and 5.uCi/ml [3HJ-leucine. The specific activiry 
of cellular leucine pools was determined from HPLC analysis ofPTC-amino 
acids derived from dialysates of the cell layer. Total incorporation (lower 
pallel) represents the sum of nondialyzable radioactiviry in the medium and 
cell layer. Total protein synthesis (middle pallel) was calculated using total 
incorporated counts, the DNA content of the cell layer, and the specific 
activiry of the cellular leucine pools. Relative TE synthesis (upper panel) was 
derived by dividing absolute TE production, determined by ELISA, by total 
protein synthesis. Because the leucine pools may not have been in equilib-
rium, the values for total protein synthesis and elastin synthesis are expressed 
as arbitrary units. Tropoelastin incorporation and relative production data 
represent the average of triplicate values ± SEM. Only one of the triplicates 
from the incorporation study was measured for specific activiry of leucine 
pools, therefore, total protein values represent single determinations (al-
though the total protein values and incorporation values are proportionally 
quite similar). 
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Figure 4. Northern blot analysis of elastin mRNA. Total cellular RNA was 
extracted in the presence of 6 M guanidine-HCl and single-stranded nucleic 
acids were pelleted through a 5.7 M CsCI gradient. The RNA fraction was 
enriched for poly (A)+-RNA, which was eluted from a poly[U]-Sepharose 
column. Equivalent amounts (2 J1g) of poly [A]+ -enriched RNA from nor-
mal and cutis laxa cell lines were electrophoresed on a 1 % agarose gel and 
transferred to Nytran (Sch leicher & Schuell) by electroblotting and hybrid-
ized to a (32P]-CTP-labeled 1.3-kb genomic fragment of the sheep elastin 
gene, pSEl -1.3. The blot was washed and exposed to x-ray film. Lanes 
contain RNA from (A) foreskin fibroblasts (5W-8), (B) normal fibroblasts 
from 2-mo-old donor (GM 5756). (e) normal fibroblasts from a 24-mo-old 
donor (GM 969A), and cutis laxa fibroblast strains: (D) DP, (E) HC, (F) KL, 
(G) KT, (l) 5S. Lane J contained sheep nuchal ligament RNA used for a size 
standard. Lane H is empry. 
seen in infancy, may be progressive or lead to death . Our studies 
suggest that, even with the early onset form of the disease, there is 
both morphologic and biochemical heterogeneity. Olsen et al [20] 
recently reported that elastin mRNA levels are reduced in several 
cutis laxa cell strains, though the findings were not correlated to 
protein production or ultrastructural morphology. Reduced elastin 
production, however, was not a universal feature in the fibroblasts 
of the present group of cutis laxa cell strains, and steady-state levels 
of elastin mRNA were selectively reduced in only 2 of 5 strains 
tested. Aside from the fact that different cell strains were tested in 
these studies, this heterogeneity may derive, at least in part, from 
interpretation of the data. Elastin mRNA levels measured by Olsen 
et al were normal or near-normal in four cell lines when compared 
with the lower limit of their normal range. The lowest elastin 
producers in the current study fell below the lower limit of the 
normal range by greater than 6- and 20-fold (KL and KT, respec-
tively). When compared with mean normal values, additional cutis 
laxa cell strains would be considered low producers in our study. In 
all, three patient strains (HC, KL, KT) synthesized significantly less 
TE on a per cell basis when evaluated by our criteria. In strain HC, 
however, the reduced synthesis of total TE reflected the decreased 
protein production. These data suggest that defects in synthesis of 
TE may represent one of several mechanisms that bring about the 
cutis laxa phenotype. . 
Mechanisms of Reduced Production of Tropoelastin Di-
minished TE production by KL and KT cell strains is explained by a 
similar reduction of elastin gene transcripts (mRNA). Levels of total 
cellular RNA production, and the proportion that was poly [A]+-
RNA, did not differ significantly between these and normal cell 
strains. 
Exceptionally low TE mRNA levels in these two cell strains may 
derive from altered transcriptional rates or decreased stability of the 
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transcripts. Both cell strains have apparently normal gene structure 
in those regions accessible by our probes, and gene copy number is 
normal. Elastin gene structure is complex and transcripts are subject 
to alternative splicing [33,34]; therefore, we cannot exclude the 
possibility that maturation of the mRNA is defective. Transcription 
could be secondarily repressed as a result of altered TE secretion. 
Frisch 'et al [35] have previously shown that a monensin-induced 
blockage ofTE secretion in rat aortic smooth muscle cells results in 
the reduced cellular content of elastin mRNA, suggesting that TE 
gene expression may be under feedback regulation. Structural de-
fects in elastin that affect the secretory process have not been identi-
fied, although ascorbate-mediated repression of elastin production 
could act in this way (LuValle, Quaglino, Davidson, in prepara-
tion). General protein secretion by these cells was found to be nor-
mal, although we have not omitted the possibility of an elastin-spe-
cific secretory defect. 
Tropoelastin production by cutis laxa fibroblast strain KT was 
consistently lower than all other cell strains tested. Deficient elastin 
production in vitro by this strain agrees with ultrastructural find-
ings. In a previous study, using these fibroblasts, an increased syn-
thesis of GP140 (type VI collagen) was also noted [15]. Contrary to 
earlier reports [36,37] there is no current evidence that either 
GP140 or type VI collagen is specifically associated with elastic 
fibers or microfibrillar components [18,38,39]. Therefore, the sig-
nificance of increased synthesis of type VI collagen in the face of 
decreased TE synthesis is uncertain. 
As previously discussed, elastin in the papillary and reticular 
dermis of HC was decreased and arranged in smatI bundles instead 
of long fibers, and the microfibrillar component was dissociated 
from the amorphous elastin [16]' Normalized TE production by 
HC fibroblasts in the presence of increased (20%) FCS (data not 
shown) could reflect reduced responsiveness to one or more serum-
derived growth factors. Alternatively, the biochemical abnormality 
in HC could be at the level of primary structure and could affect the 
proper association of elastin and microfibrillar components. 
In addition to strain HC, three other cutis laxa cell strains (SH, 
DP, and SS) produced TE at normal or near normal levels. Microfi-
brillar component was in instances obscured by, increased relative 
to, or sometimes separated from the amorphous elastic component. 
Present findings suggest that elastin synthesized in some cases of 
cutis laxa may not associate normally with microfibrillar matrix or, 
alternatively, other components of the elastic fiber system may be 
affected and fail to interact with elastin. Low ceruplasmin levels of 
strain SH, taken together with the small collagen fibers and mini-
mal amounts of elastic fibers, could suggest aberrant cross-link for-
mation secondary to impaired copper metabolism or EDS IX. No 
hyperextensibility of the joints was noted, however, and the re-
duced copper and ceruplasmin levels appeared to derive from a 
combination of premature birth, low birth weight, dietary intake, 
and liver disease. 
We have attempted to correlate biochemical and ultrastructural 
defects in elastin accumulation, in an effort to establish markers for 
classification of clinically diagnosed cutis laxa. The approach under-
taken in this study, however, was not sufficient to detect all poten-
tial defects in elastin metabolism. Human skin fibroblasts secrete 
uncross-linked TE into culture medium, and these studies did not 
measure defects in cross-linking or fiber formation that could result 
from defects in lysyl oxidase metabolism, structural changes in the 
polypeptide, or other factors that may influence normal fiber for-
mation. 
Although we found no evidence of increased degradation, TE 
synthesized in vitro is more susceptible to degradation than its 
cross-linked counterpart [40,41]. Loss of elastin in vivo may result 
from impaired cross-linking, increased elastase levels [19,23], or 
decreased expression of proteinase inhibitors [42]. Finally, the prop-
erties that microfibrillar component may confer on normal elastic 
tissue function are not yet known [18]. Fibrillin, a 350-kD glyco-
protein with high cysteine content, localizes to elastic fiber microfi-
brils [43]' and its metabolism probably plays a significant role in 
elastic fiber formation. 
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These studies 1) provide evidence of the presence of altered elas-
tin protein and RNA metabolism in some patients with congenital 
forms of cutis laxa, 2) underscore the biochemical and ultrastruc-
tural heterogeneity within the clinical classification, and 3) empha-
size the importance of both kinds of data to identify abnormalities in 
cutaneous disease. We hope that more thorough characterization of 
these mutations will help in understanding the control of elastin 
expression and fibrillogenesis. 
We thank the fal/lilies atld their piJysicialls for cooperating with this study and 
providing skin biopsies of the a.D'ected childrell. 
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